Roivant Sciences Ltd. Free Cash Flow 2021–2026
Roivant Sciences Ltd. reported $-758.56M of free cash flow for fiscal 2026. That was 10.1% higher than fiscal 2025. Compared with fiscal 2021, the change was -36.0%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2026 | $-758.56M | +10.1% |
| FY 2025 | $-844.05M | -10.1% |
| FY 2024 | $-766.65M | +10.4% |
| FY 2023 | $-856.08M | -23.1% |
| FY 2022 | $-695.16M | -24.6% |
| FY 2021 | $-557.94M | — |
Source: Roivant Sciences Ltd. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ROIV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Roivant Sciences Ltd. reported $-758.56M of free cash flow for fiscal 2026. That was 10.1% higher than fiscal 2025. Compared with fiscal 2021, the change was -36.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Roivant Sciences Ltd.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeRoivant Sciences Ltd. — frequently asked questions
What is Roivant Sciences Ltd.'s free cash flow?
Roivant Sciences Ltd. (ROIV) reported free cash flow of $-758.56M for fiscal year 2026, per its SEC filings.
Where does this data come from?
Figures are computed from Roivant Sciences Ltd.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.